Thailand’s Pharmacy Sector Faces Major Shift as Telepharmacy Services Expand

According to a report by Prachachat Business, the Thai Food and Drug Administration (FDA) has officially certified seven major corporations to operate telepharmacy services. This development marks a significant turning point for the pharmaceutical retail industry in Thailand, as prominent players—including major delivery platforms and convenience store chains—are now authorized to expand their services into this sector.

This shift has raised alarms within the Pharmacy Association, which warns that the country’s 18,000 independent pharmacies may struggle to compete. The association cites concerns over the inability of smaller operators to match the operational costs and the gross profit (GP) structures of these large-scale entities, potentially threatening the survival of many local businesses. In response, the association has proposed a 'Pharmacy Hub' model as a potential strategy to help smaller shops remain viable in the changing landscape.

For residents and travelers, this change may soon make accessing medication more convenient through digital platforms. However, the long-term impact on the availability of local, neighborhood pharmacies remains to be seen. It is not yet confirmed how these new services will be integrated into existing healthcare regulations or what specific safeguards will be implemented to ensure patient safety during remote consultations. The industry continues to monitor how this regulatory approval will reshape the competitive landscape for pharmaceutical access across the country.